We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxonica | LSE:OXN | London | Ordinary Share | GB00B0D09P49 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.125 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/11/2007 14:48 | Some sort of knak by M.M.s-they know all the tricks,never tell the punter[investor]unti | mbugger | |
23/11/2007 15:54 | Top % riser of the day- anyone know why? | mangal | |
22/11/2007 20:34 | cootuk, as you wrote, 9 months operational cash. Seems like we need some serious business, in terms of revenue & cashflow - within the next 6 months or so. Or else............. powwow, yes, people are here, but probably cannot be bothered to post, this has seemed fairly hopeless for a long time. In fact since the Turkish delight. Happen the Dragon's Den man (who is subscribing for a wedge of shares in this fundraising)- is getting things moving here. It has gone from (respectable) tipsters stuff, to a dog - in a matter of months. Though the fact that the VCT's & co are putting up more money, might suggest they know of impending contracts/revenue streams that we don't. I guess it is down to faith, until we get hard evidence. Time will tell. As usual. | damanko | |
22/11/2007 17:00 | So enough cash for another 9 months but a large dilution for those who have already lost out on the share price anyway. | cootuk | |
22/11/2007 16:10 | no one here ? | powwow | |
16/11/2007 04:48 | No news of fundraising yet, or of Envirox in the US. Last one out turn off the lights? | cootuk | |
29/9/2007 08:56 | Take AIM: Dragon's Den helps Oxonica turn Turkey Published: 17:21 Friday 28 September 2007 By Douglas Bence, Companies Correspondent Nanomaterials group Oxonica is involved with improving fuel combustion, providing ultra violet screening in sun care products and tagging objects used in security identification. For those that may not know, nano is a Latin word meaning small, in a modern sense a one thousand millionth part. It was being small, if not nano-sized that gave AIM-listed Oxonica the biggest problem in its history earlier this year, forcing its shares to be suspended and triggering a hunt for new capital. One of its best known products is Envirox, a fuel catalyst that improves consumption and reduces emissions. It was tested by transport group Stagecoach in London before it sold that part of its bus operations to the Australian group Macquarie. Oxonica's energy division had a contract with Petrol Ofisi, Turkey's leading oil company. Most of Turkey's fuel comes from Russia and tends to have a high, and environmentally undesirable, sulphur content that was hitting Petrol Ofisi's market share. It was thought that these disadvantages could be reduced by Envirox. Tests were done and the benefits measured. But for a science-based company like Oxonica, which spun out of Oxford University in 1999, there were too many variables: different vehicles on sometimes dubious road surfaces with different drivers in a range of environments and weather conditions. Although there was plenty of positive anecdotal evidence, Petrol Ofisi felt it insufficiently hard for it to promote the treated fuel as aggressively as planned. The results were dismissed as inconclusive and Oxonica fired. The size of the deal and the initial uncertainties associated with its loss gave the board no option but to suspend the shares at 117.5p on 27 April. They had been pushed up to 150p when the Petrol Ofisi contract was landed in August 2006 and on 24 October peaked at 172.5p. Oxonica clarified its position with Petrol Ofisi, tried to rebuild the trial programme and took drastic steps to reduce costs. But when the share suspension was lifted on 5 June, Oxonica's shares plunged to 34p and bottomed on 15 June at 30.5p. 'We did all the things you would expect as well as initiating a detailed strategic review of the business the conclusion of which was to raise additional funds,' chief executive Kevin Matthews told Citywire. Although the discussions are now at an advanced stage to raise a currently undisclosed amount, but probably around £7 million, the story changes at this point. Oxonica came to AIM in July 2005 with a private placing targeting individuals rather than City institutions. The second largest shareholder with 16% is entrepreneur Richard Farleigh, a former potential investor in the reality TV programme Dragon's Den. He has become chairman of Oxonica and is masterminding the fundraising, again with individuals. It is hoped that this will increase liquidity in the stock, which closed today 2p higher 36.5p with just 13 deals involving under 28,000 shares, and attract institutional interest. Revenue in the six months to 30 June increased 142% to £3.1 million against £1.3 million last time. But £2.1 million of this against £300,000 comprised sales of Envirox to Petrol Ofisi. Excluding these, Envirox revenue was slightly lower than in the first half of 2006 mainly due to the loss of the Stagecoach London depots following the sale to Macquarie. As well as selling to the energy industry, Oxonica also deals with the healthcare, materials and security markets. The security business has a number of orders for delivery in the second half and a research and development agreement has been reached with the US company BD for diagnostic work. Optisol is an ultra violet protection system designed for use in sunscreen creams and products to treat premature aging. Sales doubled to £265,000 in the half year against £108,000 last time. The product is now used in 27 formulations by 14 customers including Boots in nine countries. Although gross profit increased 59% to £1.2 million against £800,000, the operating loss for the first half was £3.2 million against £2.9 million. Citywire Verdict: Definitely a company to watch, and a share worth acquiring for the medium to long term. | ariane | |
27/9/2007 15:55 | That looks to me like OXN can't afford to do the funding so BD will take the lions share of the technology...if it succeeds. | cootuk | |
23/9/2007 16:40 | Being a fairly new shareholder of this company, I was impressed when Richard Farleigh upped his interest. I think this a company of the future. Is it going to come good again? Any ideas. | jeaniehow | |
11/9/2007 07:05 | Oxonica New distribution agreement RNS Number:6241D Oxonica plc 10 September 2007 11 September 2007 Oxonica plc New supply and distribution agreement between Oxonica Energy and Nyacol Nano Technologies Inc Oxonica plc ("Oxonica"), a leading international nanomaterials group, today announces the signing of a new agreement between its subsidiary Oxonica Energy Limited ("Oxonica Energy") and Nyacol Nano Technologies, Inc ("Nyacol"). The signing of this two part agreement establishes a strategic relationship between the companies which secures the long term cost effective supply of Oxonica's EnviroxTM diesel fuel catalyst and assigns the distribution rights in certain Asian territories to Nyacol. Dr Kevin Matthews, CEO of Oxonica, said "The relationship with Nyacol establishes a strong supply position and also through Nyacol's extensive network in Asia the potential to accelerate the uptake of EnviroxTM in the region'' Robert J Nehring Jr., CEO of Nyacol, said "This agreement allows Nyacol to combine its key strengths of nanomaterial manufacturing and an Asian network with Oxonica's application expertise to sell EnviroxTM diesel fuel catalyst into a region where we believe there is the potential for significant growth. Our relationship with Oxonica is developing all the time and I see the opportunity for both companies to benefit greatly from the agreement." For further information, please contact: Oxonica plc 01865 856 700 Kevin Matthews, Chief Executive Richard Clarke, Finance Director The Broadcast PR Business 0207 812 6624 Matthew Locke Notes to Editors About Oxonica plc - www.oxonica.com Oxonica (AIM: OXN.L) is one of the leading International nanomaterials groups with products already launched into international markets and is listed in London on the AIM market. It was spun-out from Oxford University in 1999. Oxonica's mission is to focus on the development of innovative commercial solutions for international markets using its expertise in the design and application of nanomaterials. It owns a portfolio of demand driven products that offer substantial benefits to the target markets of energy, healthcare, materials and security. The Group currently has four operating divisions: Oxonica Energy, Oxonica Healthcare, Oxonica Materials and Oxonica Security. Oxonica has already launched products into international markets. Lead products include: * EnviroxTM Fuel Borne Catalyst - a nanocatalyst improving fuel economy and reducing emissions * OptisolTM UV Absorber - a revolutionary photostable UV protection system designed to optimise the performance of quality sunscreens and anti-premature aging products Oxonica is also active in searching for the next generation of products and is already engaged in developing transformational detection technologies which will enable a new generation of ultrasensitive multiplex diagnostic tools for the clinical diagnostic life science and security markets. In addition, the company is developing other UV absorber technologies into polymer systems and coatings, based on similar technologies to that used in OptisolTM. About Nyacol Nano Technologies, Inc - www.nyacol.com Nyacol Nano Technologies Inc. was founded in 1969 and is a privately held corporation. Nyacol has developed a variety of proprietary nano-particle technologies for manufacturing specialized inorganic colloids. Its founders created a unique process for manufacturing colloidal silica, or silica sol. These nano-particle techniques have been expanded to metal oxides such as antimony pentoxide and the oxides of aluminium, cerium, tin, yttrium and zirconium. The special properties and adaptability of Nyacol's colloidal silica, and metal oxides have earned a worldwide reputation for reliability, quality and adaptability. This information is provided by RNS The company news service from the London Stock Exchange END AGRFGGMLLGMGNZM | ariane | |
26/8/2007 13:47 | I could understand a general working party to influence 'decision makers' in the EU regulatory side and the EPA. | cootuk | |
26/8/2007 09:08 | Hm.... excellent verse. For now, then; Always look on the bright side of life.. | damanko | |
25/8/2007 20:52 | I never heard such a pile of junk in all my life. Nanotech code of conduct, LMAO. What they infact mean is Nanotech is buzz word and they want to control who uses it... Nevermind what they ever might do in future like ever becoming profitable. ... It could almost be a Monty Python sketch.. "We are Oxford knights of the nanotech table.. We raise cash whenever we're able.. We laugh all night, deciding what nanotech's right.. (something else..). This company needs focus.. | officerdigby | |
15/8/2007 10:22 | I assume one of the core codes of conduct for suppliers to the industry will that they must be solvent and have a sustainable business. It therefore beggars belief that Oxonica think they are the appropriate people to tell the industry what to do. I suggest they concentrate on the critical matter of revenue and cash generation and cost reduction rather than joining and academic-induced mutual back-slapping party! Or else, by the time any material conclusions are reached (if any) there will be no company left to benefit. IMHO the press release demonstrates just how far away are Oxonica's navel-gazing management from recognizing the criticial aspects on how to run a business. | bearfoot | |
09/8/2007 09:46 | Oxonica NanoTech Code of Conduct RNS Number:8012B Oxonica plc 09 August 2007 PRESS RELEASE Industry leaders to develop nanotech Code of Conduct Oxford, UK, August 8 2007. Leading International nanomaterials group Oxonica is joining forces with other industry experts in a new initiative to develop a Code of Conduct for businesses working with nanotechnologies. The aim of the voluntary Code will be to establish good practice for businesses involved in all aspects of emerging nanotechnologies including research, development, manufacturing, distribution and retailing. Oxonica is a member of the Nanotechnology Industry Association, one of the four founding partners responsible for developing the Code. A working party has been formed with other groups including business and non-governmental organisations along with scientists and social scientists. Confirmed members of the working group so far include - amongst others - the chemical company BASF, Unilever, Tesco, the consumer group Which? and development NGO Practical Action. Kevin Matthews, CEO of Oxonica said "At Oxonica we are committed to developing nanotechnology based products, responsibly in partnership with other leading companies that address major global issues and market needs. In this rapidly developing market we are pleased to be working with other industry leaders to develop a Code that will set the standards for the nanotechnology community to operate within". The initiative to develop a Code of Conduct for businesses working with nanotechnologies has been launched by the Royal Society, Insight Investment, the Nanotechnology Industries Association and the Nanotechnology Knowledge Transfer Network. The Code will be voluntary with companies being encouraged to publicly explain how they comply with its principles through, for example statements in annual or corporate responsibility reports. The Code will set out expected corporate behaviours and management processes rather than an auditable standard, although indicators of compliance may be developed. An open consultation will take place in Autumn 2007 when a draft code will be available for comment. More information is available from www.responsiblenanoc 2008. Ends Notes to Editors About Oxonica plc - www.oxonica.com Oxonica (AIM: OXN.L) is one of the leading International nanomaterials groups with products already launched into international markets and is listed in London on the AIM market. It was spun-out from Oxford University in 1999. Oxonica's mission is to focus on the development of innovative commercial solutions for international markets using its expertise in the design and application of nanomaterials. It owns a portfolio of demand driven products that offer substantial benefits to the target markets of energy, healthcare, materials and security. The Group currently has four operating divisions: Oxonica Energy, Oxonica Healthcare, Oxonica Materials and Oxonica Security. Oxonica has already launched products into international markets. For more information on Oxonica please contact: Nicole Love, Ogilvy Public Relations Worldwide, tel: 0207 309 1103, email Nicole.love@uk.ogilv This information is provided by RNS The company news service from the London Stock Exchange END NRAKKLBBDVBXBBK | waldron | |
24/7/2007 19:51 | Having bought at 60 and not sold out at 80 I feel pretty stupid as I am down 46% (only put in small amount so didnt bother with my usual 10% stop) Though I might ride it out for a few months see if Farleigh can do anything to remedy his investing reputation. But things dont look good. An expensive and overwight management team no sustainable product lack of information on what they plan to win orders and increase revenue / cut costs I want to be an optimist but can anyone give me a reason to jump in at these levels and not face a complete whitewash | angry manc | |
22/7/2007 11:56 | i think theres far to many on the board...more members on the board the more Big paychecks go to them | petersmith6 | |
21/7/2007 15:03 | Times today mentions farleigh joining the board- it mentions his perma-tan as well! | bluepill | |
19/7/2007 10:33 | it looks like a mini coup today i can't see that the chairman is a reason for poor sales OXN has a lot of directors for a small company... | nod | |
12/7/2007 16:18 | So it looks like the Petrol Ofisi trial may have been to see how well this 'Compund B' performed compared to Neuftec 'Compund A' as coating on high sulphur diesel in the real world. | cootuk | |
12/7/2007 15:20 | Yo yo continues, though today's RNS looks to be positive. The main thrust: "Neuftec has now confirmed that its granted European patent in the UK (EP(UK) 1299508) does not cover the Envirox(TM) formulation currently sold by Energy and that Energy's dealings with this Envirox(TM) would not infringe any claim of this patent. The only issue that remains is a narrow technical argument by Neuftec that because of the wording of the licence agreement royalties are due on this Envirox(TM) formulation up to the date the licence agreement was terminated. Energy's outside solicitors and counsel have advised Energy that it has a strong case on this specific point. At 31 December 2006, Oxonica was carrying the Neuftec licence in the balance sheet as an intangible fixed asset at a value of £148,000. This has been written-off subsequent to the year-end. Legal costs are being expensed as incurred. As mentioned above, Neuftec has now confirmed that this granted European patent in the UK does not cover Product B, the EnviroxTM formulation currently sold by Oxonica, and that Energy's dealings with Product B would not infringe any claim of this patent." | damanko |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions